PL2408446T3 - Zastosowanie kompozycji farmaceutycznych zawierających mesembrenon - Google Patents
Zastosowanie kompozycji farmaceutycznych zawierających mesembrenonInfo
- Publication number
- PL2408446T3 PL2408446T3 PL10710448T PL10710448T PL2408446T3 PL 2408446 T3 PL2408446 T3 PL 2408446T3 PL 10710448 T PL10710448 T PL 10710448T PL 10710448 T PL10710448 T PL 10710448T PL 2408446 T3 PL2408446 T3 PL 2408446T3
- Authority
- PL
- Poland
- Prior art keywords
- mesembrenone
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- containing mesembrenone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200902003 | 2009-03-20 | ||
| PCT/IB2010/051132 WO2010106494A1 (en) | 2009-03-20 | 2010-03-16 | Use of pharmaceutical compositions containing mesembrenone |
| EP10710448.1A EP2408446B1 (en) | 2009-03-20 | 2010-03-16 | Use of pharmaceutical compositions containing mesembrenone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2408446T3 true PL2408446T3 (pl) | 2020-03-31 |
Family
ID=42167479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10710448T PL2408446T3 (pl) | 2009-03-20 | 2010-03-16 | Zastosowanie kompozycji farmaceutycznych zawierających mesembrenon |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8552051B2 (pl) |
| EP (1) | EP2408446B1 (pl) |
| AU (1) | AU2010224485B2 (pl) |
| DK (1) | DK2408446T3 (pl) |
| ES (1) | ES2759675T3 (pl) |
| PL (1) | PL2408446T3 (pl) |
| PT (1) | PT2408446T (pl) |
| WO (1) | WO2010106494A1 (pl) |
| ZA (1) | ZA201106703B (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010224486B2 (en) | 2009-03-20 | 2014-04-24 | Hg&H Pharmaceuticals (Pty) Ltd | Sceletium extract and uses thereof |
| GB201101075D0 (en) | 2011-01-21 | 2011-03-09 | Labminds Ltd | Automated solution dispenser |
| EA029760B1 (ru) * | 2011-02-07 | 2018-05-31 | Сифарм Сарл | ПРИМЕНЕНИЕ КОМПОЗИЦИИ ПРОСТАЦИКЛИНА И ИНГИБИТОРА ФОСФОДИЭСТЕРАЗЫ 4 ИЛИ ИХ АНАЛОГОВ ДЛЯ ЛЕЧЕНИЯ МУКОВИСЦИДОЗА И УВЕЛИЧЕНИЯ цАМФ В ЭПИТЕЛИАЛЬНЫХ КЛЕТКАХ |
| AP2015008663A0 (en) | 2013-02-19 | 2015-08-31 | Pfizer | Azabenzimidazole compounds as inhibitors of PDE4 isozymes for the treatment of cns and other disorders |
| US9149457B2 (en) | 2013-09-27 | 2015-10-06 | Justin SHER | Nutraceutical composition for PDE4 inhibition, enhanced dopamine metabolism and long term potentiation |
| WO2015130994A1 (en) * | 2014-02-28 | 2015-09-03 | Tripp Matthew L | Phosphodiesterase-4 inhibiting phytochemical compositions |
| JP6713982B2 (ja) | 2014-07-24 | 2020-06-24 | ファイザー・インク | ピラゾロピリミジン化合物 |
| PE20170295A1 (es) | 2014-08-06 | 2017-03-30 | Pfizer | Compuestos de imidazopiridazina |
| CN107835712B (zh) | 2015-02-06 | 2021-09-10 | 莱伯曼兹有限公司 | 自动化溶液分配器 |
| WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
| WO2019021196A1 (en) * | 2017-07-26 | 2019-01-31 | Hg&H Pharmaceuticals (Pty) Ltd | MESEMBRENOL AND / OR MESEMBRANOL FOR THE PROPHYLAXIS AND TREATMENT OF PATIENTS SUFFERING FROM EPILEPSY AND RELATED DISEASES |
| WO2021086345A1 (en) * | 2019-10-30 | 2021-05-06 | Plant Synergy Inc. | High yield extraction method for and products of kanna plants |
| US10864239B1 (en) | 2019-10-30 | 2020-12-15 | Plant Synergy Inc. | High yield extraction method for and products of kanna plants |
| US11999694B2 (en) | 2021-10-29 | 2024-06-04 | Sensorium Therapeutics, Inc. | Delivery of therapeutic alkaloid compounds |
| WO2024207030A1 (en) * | 2023-03-28 | 2024-10-03 | Stellenbosch University | Composition comprising a sceletium extract and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3604112A1 (de) | 1986-02-10 | 1987-08-13 | Bernhard Dr Janiak | Pflanzenextrakte von mesembryanthemaceen sowie solche enthaltende schaedlingsbekaempfungsmittel und arzneimittel |
| US6271001B1 (en) | 1995-03-23 | 2001-08-07 | Bio Polymers Pty. Ltd. | Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications |
| ZA974576B (en) * | 1996-06-04 | 1998-02-04 | Farmarc Nederland Bv | Pharmaceutical composition. |
| SE9804064D0 (sv) | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| WO2001057060A1 (en) | 2000-02-01 | 2001-08-09 | Human Genome Sciences, Inc. | Bcl-2-like polynucleotides, polypeptides, and antibodies |
| GB0111579D0 (en) | 2001-05-11 | 2001-07-04 | Holford & Associates Ltd | Oral supplement |
| US7323334B2 (en) | 2002-10-04 | 2008-01-29 | The Regents Of The University Of California | Screening and therapeutic methods relating to neurogenesis |
| US6969702B2 (en) | 2002-11-20 | 2005-11-29 | Neuronova Ab | Compounds and methods for increasing neurogenesis |
| WO2004045592A2 (en) | 2002-11-20 | 2004-06-03 | Neuronova Ab | Compounds and methods for increasing neurogenesis |
| WO2004053071A2 (en) | 2002-12-09 | 2004-06-24 | Judith Kelleher-Andersson | Method for discovering neurogenic agents |
| EP1622577A4 (en) | 2003-04-17 | 2007-09-26 | Univ Leland Stanford Junior | PREVENTION OF DEFICIT NEUROGENESIS DISORDERS WITH ANTI-INFLAMMATORY AGENTS |
| US7763588B2 (en) | 2003-06-13 | 2010-07-27 | The Salk Institute For Biological Studies | Method for increasing cognitive function and neurogenesis |
| WO2005017189A2 (en) | 2003-08-05 | 2005-02-24 | University Of Florida Research Foundation, Inc. | Neural cell assay |
| EP1771435A4 (en) * | 2004-06-19 | 2008-02-13 | Human Biomolecular Res Inst | MODULATORS OF NEUROTRANSMITTERS OF THE CENTRAL NERVOUS SYSTEM |
| AU2010224486B2 (en) | 2009-03-20 | 2014-04-24 | Hg&H Pharmaceuticals (Pty) Ltd | Sceletium extract and uses thereof |
-
2010
- 2010-03-16 DK DK10710448T patent/DK2408446T3/da active
- 2010-03-16 PL PL10710448T patent/PL2408446T3/pl unknown
- 2010-03-16 AU AU2010224485A patent/AU2010224485B2/en active Active
- 2010-03-16 ES ES10710448T patent/ES2759675T3/es active Active
- 2010-03-16 US US13/256,686 patent/US8552051B2/en active Active
- 2010-03-16 PT PT107104481T patent/PT2408446T/pt unknown
- 2010-03-16 WO PCT/IB2010/051132 patent/WO2010106494A1/en active Application Filing
- 2010-03-16 EP EP10710448.1A patent/EP2408446B1/en active Active
-
2011
- 2011-09-13 ZA ZA2011/06703A patent/ZA201106703B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2759675T3 (es) | 2020-05-11 |
| WO2010106494A1 (en) | 2010-09-23 |
| ZA201106703B (en) | 2012-05-30 |
| US20120041045A1 (en) | 2012-02-16 |
| US8552051B2 (en) | 2013-10-08 |
| PT2408446T (pt) | 2019-12-18 |
| EP2408446B1 (en) | 2019-09-11 |
| EP2408446A1 (en) | 2012-01-25 |
| AU2010224485B2 (en) | 2014-04-17 |
| AU2010224485A1 (en) | 2011-10-20 |
| DK2408446T3 (da) | 2019-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201106703B (en) | Use of pharmaceutical compositions containing mesembrenone | |
| PT2482812T (pt) | Composições farmacêuticas compreendendo bi-1356 e metformina | |
| HK1218881A1 (zh) | 藥物組合物 | |
| EP2451274A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EP2500038A4 (en) | PHATMACEUTICAL COMPOSITION FOR EXTERNAL USE / | |
| IL215497A0 (en) | Oxadiazile derivatives and pharmaceutical compositions containing them | |
| EP2552447A4 (en) | STABLE PHARMACEUTICAL COMPOSITION OF IMATINIB | |
| ZA201203719B (en) | Pharmaceutical compositions of sevelamer | |
| ZA201107122B (en) | Stable pharmaceutical compositions of diclofenac | |
| EP2515880A4 (en) | NEW PHARMACEUTICAL COMPOSITIONS OF RANOLAZINE | |
| ZA201200659B (en) | Pharmaceutical composition of isoniazid | |
| PL2391353T3 (pl) | Kompozycje farmaceutyczne trimetazydyny | |
| GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
| IL219018A (en) | Radzolid Pharmaceuticals and Uses | |
| PT2471520T (pt) | Composições farmacêuticas de levetiracetam | |
| HK1131039A1 (en) | Pharmaceutical use of sophoricoside | |
| PL2407159T3 (pl) | Kompozycje farmaceutyczne olmesartanu | |
| GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
| PL2277511T3 (pl) | Kompozycje farmaceutyczne lewetiracetamu o przedłużonym uwalnianiu | |
| ZA201200531B (en) | Pharmaceutical composition of rifampicin | |
| PL2519261T3 (pl) | Płynna kompozycja farmaceutyczna doustna nifedypiny | |
| HU0900698D0 (en) | Pharmaceutical compositions of enhanced stability | |
| GB0903945D0 (en) | Pharmaceutical compounds and compositions | |
| GB0919055D0 (en) | Pharmaceutical compounds and compositions | |
| GB0908069D0 (en) | Pharmaceutical compounds and compositions |